Developer docs
API playgroundTry for free, no card

Search company profiles

Nucleus Global

Full company profile

uuid000b5zn

Namestring
Nucleus Global
Legal namestring
Nucleus Global
Company typeenum
Private
Founded yearint
1986
Descriptiontext

Nucleus Global is a medical communications agency serving pharmaceutical, biotechnology, and medical device companies. Founded in 1986 by Stephen Cameron in London, the firm delivers science-led communications services spanning strategic planning, publications planning and execution, promotional medical communications, medical education, external expert engagement, scientific event management, patient engagement, internal communications and training, creative design, digital solutions, clinical trial support, and value communications covering HEOR, market access, and pricing/reimbursement. The company operates a portfolio of twelve integrated service modules delivered through an in-house creative digital agency and approximately 750-900 professionals across ten offices in the UK, US, Germany, Singapore, and Australia.

The firm's technology stack centers on its services portfolio plus access to iON AI, an AI-powered intelligence platform launched in March 2025 by parent Inizio Medical to address Medical Affairs challenges through text-based generative capabilities. Core delivery relies on scientific writing expertise, journal publications workflows, and creative/digital production rather than proprietary software products. The platform architecture, underlying AI models, and training data assets are not publicly disclosed.

Nucleus Global operates a B2B professional services revenue model with quote-based engagements and long-term enterprise partnerships. The go-to-market motion is sales-led, targeting large pharma companies through strategic account management and Senior Vice Presidents overseeing Growth Operations and Business Growth and Strategy. Pricing is not publicly disclosed. The company holds a 2024 MM+M Gold Award for Medical Communications, Education or Affairs Agency of the Year and serves 90-plus clients globally, with named enterprise accounts including top-tier pharmaceutical firms. Nucleus Global is a subsidiary of Inizio Medical, which is owned by Copec, and operates alongside sister agencies Ashfield MedComms, ApotheCom, and MEDiSTRAVA within the broader Inizio Medical network.

Short descriptiontext

Nucleus Global is a medical communications agency serving pharmaceutical, biotechnology, and medical device companies. The firm delivers scientific publications, medical education, and strategic communications through approximately 750-900 professionals across ten offices in the UK, US, Germany, Singapore, and Australia, as part of the Inizio Medical network.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
501–1,000
akta.pro rankint
HeadquartersLondon, United Kingdom
HQ citystring
London
HQ countrystring
United Kingdom
HQ regionstring
Europe
Markets served

Serves global market

Offices10 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical communications services, scientific publications planning, pharmaceutical communications agency, medical affairs consulting, healthcare communications
Industry1 code
PRIMARYHLAGAOAG
Medical Affairs, Scientific Communications & HEOR FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)
NAICS code1 code
  • Other Scientific and Technical Consulting Services54169
SIC code1 code
  • Services-Commercial Physical & Biological Research8731
Product category
Medical Communications Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Communications Services
TypeProfessional Services
Description

Professional services revenue model providing medical communications consulting to pharmaceutical, biotech, and medical device industries. Services include strategic planning, publications planning, promotional medical communications, medical education, external expert engagement, scientific event management, patient engagement, internal communications and training, creative design, digital solutions, clinical trial support, and value communications (HEOR, market access, pricing and reimbursement).

nucleusglobal.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Nucleus Global is a global medical communications agency delivering strategic, scientific, and creative communications services to pharmaceutical, biotechnology, and medical device companies. Its core offering spans strategic planning, scientific publications planning and execution, promotional medical communications, medical education, external expert engagement, scientific event management, patient engagement, internal communications and training, creative design, digital solutions, clinical trial support, and value communications (HEOR, market access, pricing and reimbursement). The agency also leverages the parent-group iON AI platform to support Medical Affairs capabilities.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Extended services to 24-hour/day coverage through APAC team presence
+1 more record
Product overview1 text field

Nucleus Global is a global medical communications agency and part of Inizio Medical, offering a portfolio of integrated service modules for the pharmaceutical, biotech, and medical device industries. The core offering includes strategic planning, publications planning, promotional medical communications, medical education, external expert engagement, scientific event management, patient engagement, internal communications and training, creative design, digital solutions, clinical trial support, and value communications. The company has also launched iON AI, an AI-powered intelligence platform specifically designed to transform Medical Affairs capabilities. Services are delivered through a global team of approximately 750-900 professionals across Europe, US, and APAC regions, with internal creative and digital capabilities integrated across all projects.

Product and service13 records
1Strategic Planning and Support
CategoryMedical Communications Strategy
Description

Develops insight-driven communications strategies that translate into results-driven plans of action for pharmaceutical, biotechnology, and medical device clients.

2Publications Planning and Execution
CategoryScientific Publications
Description

Accurate, transparent, and compliant editorial support focused on first-submission acceptance from leading journals, covering scientific publications for pharmaceutical and biotech clients.

3Promotional Medical Communications
CategoryPromotional Medical Communications
Description

Science-backed commercial strategy design and implementation that moves HCP mindset and maximizes a brand's market potential for pharmaceutical clients.

4Medical Education
CategoryMedical Education
Description

Turns data and research into engaging, creative educational content delivered in print, digital, and virtual media formats for healthcare professional audiences.

5External Expert Engagement
CategoryExpert Engagement
Description

Identifies, maps, engages, and develops relationships with healthcare opinion leaders using best practices for collaboration on behalf of pharma and biotech clients.

6Scientific Event Management
CategoryEvent Management
Description

Manages scientific events from advisory boards to international symposia, supporting both virtual and in-person formats for pharmaceutical clients.

7Patient Engagement
CategoryPatient Engagement
Description

Connects brands to patients and patient advocates throughout the product lifecycle with clear, creative, and accessible communications.

8Internal Communications and Training
CategoryInternal Communications and Training
Description

Helps brand teams achieve internal alignment and collaboration through training and communications programs.

9Creative Design
CategoryCreative Design
Description

Provides leading-edge technology paired with creativity and visual design for data-driven communications across print, digital, and virtual media.

10Digital Solutions
CategoryDigital Solutions
Description

Creates digital solutions at the intersection of technology and scientific expertise for modern audiences ranging from medical experts to patients.

11Clinical Trial Support
CategoryClinical Trial Support
Description

Provides streamlined approaches for clinical trials from recruitment to results with deliberate strategy infusion for pharmaceutical and biotech clients.

12Value Communications
CategoryValue Communications (HEOR/Market Access)
Description

Provides strategic planning and tactical communications support for HEOR, market access, pricing and reimbursement, and epidemiology programs.

13iON AI
CategoryAI Platform (Medical Affairs)
Description

AI-powered intelligence platform built to address the distinct challenges of Medical Affairs. Provides AI-powered capabilities for pharmaceutical and healthcare Medical Affairs teams, supporting scientific and medical information content generation.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierCoreTypeOthers
Description

Nucleus Global is part of Inizio Medical, a global healthcare consulting and communications group. Inizio Medical provides Nucleus Global with synergies from its global network of offices and access to AI-powered technology platforms like iON AI. The Inizio Medical group includes Ashfield MedComms, ApotheCom, and MEDiSTRAVA.

Strategic tierCoreTypeOthers
Description

Nucleus Global forms part of Inizio Medical which includes Ashfield MedComms, ApotheCom, and MEDiSTRAVA. This unique position within an international network provides expanded capabilities and resources across medical communications and healthcare consulting.

3International Society of Medical Publications Professionals (ISMPP)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Nucleus Global APAC team members are active in ISMPP, driving educational activities, developing region-specific guidance on key medcomms deliverables, and contributing to the advancement of the medcomms profession through publications and professional development.

nucleusglobal.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Sister agency under Inizio Medical offering medical communications, publications, and medical affairs services to pharma and biotech. Direct peer operating in the same category, same parent network, and targeting the same enterprise pharma client base as Nucleus Global.

TypeBroad incumbent
Description

Data-driven healthcare marketing and communications agency offering medcomms, PR, and analytics. Broad incumbent peer competing for pharma communications budgets with proprietary data and AI capabilities Nucleus Global does not own.

TypeBroad incumbent
Description

Medical communications and scientific engagement agency within IPG Health, serving top-20 pharma with publications and medcomms. Broad incumbent peer with comparable services, overlapping client base, and the backing of a major holding company's healthcare network.

TypeBroad incumbent
Description

Global healthcare communications network within McCann Worldgroup offering medical communications, advertising, and consulting. Broad incumbent competing for the same pharma communications spend as Nucleus Global but at significantly larger scale and creative breadth.

TypeDirect peer
Description

Global medical communications and HEOR agency offering publications, medical affairs, market access, and patient engagement. Direct peer with overlapping service modules and similar enterprise pharma client base as Nucleus Global.

TypeDirect peer
Description

Global medical communications and consulting agency serving pharma, biotech, and medtech with publications, medical affairs, and creative services. Direct independent peer with comparable full-service MedComms capabilities and similar top-10 pharma client base.

TypeDirect peer
Description

Sister Inizio Medical agency providing medical communications, publications planning, and scientific content services to biopharma. Direct peer in the same MedComms category, sharing the Inizio Medical network and competing for the same pharma clients as Nucleus Global.

TypeBroad incumbent
Description

Large CRO and commercialization platform with a medical communications arm serving pharma and biotech. Broad incumbent with deeper clinical development capabilities but overlapping publications and medcomms services versus Nucleus Global.

TypeDirect peer
Description

Sister agency within Inizio Medical focused on medical communications and scientific content for pharma and biotech. Direct peer offering substantially the same service modules (publications, medcomms, digital) as Nucleus Global within the same parent group.

TypeOthers
Description

Global healthcare communications network within Havas offering medical communications, advertising, and consulting. Broad incumbent competing for the same pharma communications spend as Nucleus Global at significantly larger scale and creative breadth.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers4 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI capability2 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Nucleus Global

Medical Communications Servicesnucleusglobal.com

Nucleus Global is a medical communications agency serving pharmaceutical, biotechnology, and medical device companies. The firm delivers scientific publications, medical education, and strategic communications through approximately 750-900 professionals across ten offices in the UK, US, Germany, Singapore, and Australia, as part of the Inizio Medical network.

What Nucleus Global does

Nucleus Global is a medical communications agency serving pharmaceutical, biotechnology, and medical device companies. Founded in 1986 by Stephen Cameron in London, the firm delivers science-led communications services spanning strategic planning, publications planning and execution, promotional medical communications, medical education, external expert engagement, scientific event management, patient engagement, internal communications and training, creative design, digital solutions, clinical trial support, and value communications covering HEOR, market access, and pricing/reimbursement. The company operates a portfolio of twelve integrated service modules delivered through an in-house creative digital agency and approximately 750-900 professionals across ten offices in the UK, US, Germany, Singapore, and Australia.

The firm's technology stack centers on its services portfolio plus access to iON AI, an AI-powered intelligence platform launched in March 2025 by parent Inizio Medical to address Medical Affairs challenges through text-based generative capabilities. Core delivery relies on scientific writing expertise, journal publications workflows, and creative/digital production rather than proprietary software products. The platform architecture, underlying AI models, and training data assets are not publicly disclosed.

Nucleus Global operates a B2B professional services revenue model with quote-based engagements and long-term enterprise partnerships. The go-to-market motion is sales-led, targeting large pharma companies through strategic account management and Senior Vice Presidents overseeing Growth Operations and Business Growth and Strategy. Pricing is not publicly disclosed. The company holds a 2024 MM+M Gold Award for Medical Communications, Education or Affairs Agency of the Year and serves 90-plus clients globally, with named enterprise accounts including top-tier pharmaceutical firms. Nucleus Global is a subsidiary of Inizio Medical, which is owned by Copec, and operates alongside sister agencies Ashfield MedComms, ApotheCom, and MEDiSTRAVA within the broader Inizio Medical network.

Nucleus Global firmographics

Firmographics
Name
Nucleus Global
Legal name
Nucleus Global
Website
https://nucleusglobal.com
Company type
Private
Founded year
1986
Operating status
Operating
Headcount range
501–1,000 employees
Short description
Nucleus Global is a medical communications agency serving pharmaceutical, biotechnology, and medical device companies. The firm delivers scientific publications, medical education, and strategic communications through approximately 750-900 professionals across ten offices in the UK, US, Germany, Singapore, and Australia, as part of the Inizio Medical network.
Ownership category
akta.pro rank

Nucleus Global industry classification

Industry
Product category
Medical Communications Services
NAICS
Other Scientific and Technical Consulting Services (54169)
SIC
Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAOAG
Medical Affairs, Scientific Communications & HEOR FSP
Healthcare & Life Sciences/Life Science Tools & Services (CRO/CDMO/Lab Services)/Scientific Staffing & Functional Service Providers (FSP)

Keywords

  • Medical communications services
  • Scientific publications planning
  • Pharmaceutical communications agency
  • Medical affairs consulting
  • Healthcare communications

Where Nucleus Global is headquartered

Location

Headquarters

HQ city
London
HQ country
United Kingdom
HQ region
Europe

Offices10 records

Markets served

Nucleus Global business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Medical Communications Services: Professional services revenue model providing medical communications consulting to pharmaceutical, biotech, and medical device industries. Services include strategic planning, publications planning, promotional medical communications, medical education, external expert engagement, scientific event management, patient engagement, internal communications and training, creative design, digital solutions, clinical trial support, and value communications (HEOR, market access, pricing and reimbursement).

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Nucleus Global product offering

Product offering

Core offering

Nucleus Global is a global medical communications agency delivering strategic, scientific, and creative communications services to pharmaceutical, biotechnology, and medical device companies. Its core offering spans strategic planning, scientific publications planning and execution, promotional medical communications, medical education, external expert engagement, scientific event management, patient engagement, internal communications and training, creative design, digital solutions, clinical trial support, and value communications (HEOR, market access, pricing and reimbursement). The agency also leverages the parent-group iON AI platform to support Medical Affairs capabilities.

Product overview

Nucleus Global is a global medical communications agency and part of Inizio Medical, offering a portfolio of integrated service modules for the pharmaceutical, biotech, and medical device industries. The core offering includes strategic planning, publications planning, promotional medical communications, medical education, external expert engagement, scientific event management, patient engagement, internal communications and training, creative design, digital solutions, clinical trial support, and value communications. The company has also launched iON AI, an AI-powered intelligence platform specifically designed to transform Medical Affairs capabilities. Services are delivered through a global team of approximately 750-900 professionals across Europe, US, and APAC regions, with internal creative and digital capabilities integrated across all projects.

Differentiator

Problem solved

Functional benefit

Products and services

  • Strategic Planning and Support Develops insight-driven communications strategies that translate into results-driven plans of action for pharmaceutical, biotechnology, and medical device clients.
  • Publications Planning and Execution Accurate, transparent, and compliant editorial support focused on first-submission acceptance from leading journals, covering scientific publications for pharmaceutical and biotech clients.
  • Promotional Medical Communications Science-backed commercial strategy design and implementation that moves HCP mindset and maximizes a brand's market potential for pharmaceutical clients.
  • Medical Education Turns data and research into engaging, creative educational content delivered in print, digital, and virtual media formats for healthcare professional audiences.
  • External Expert Engagement Identifies, maps, engages, and develops relationships with healthcare opinion leaders using best practices for collaboration on behalf of pharma and biotech clients.
  • Scientific Event Management Manages scientific events from advisory boards to international symposia, supporting both virtual and in-person formats for pharmaceutical clients.
  • Patient Engagement Connects brands to patients and patient advocates throughout the product lifecycle with clear, creative, and accessible communications.
  • Internal Communications and Training Helps brand teams achieve internal alignment and collaboration through training and communications programs.
  • Creative Design Provides leading-edge technology paired with creativity and visual design for data-driven communications across print, digital, and virtual media.
  • Digital Solutions Creates digital solutions at the intersection of technology and scientific expertise for modern audiences ranging from medical experts to patients.
  • Clinical Trial Support Provides streamlined approaches for clinical trials from recruitment to results with deliberate strategy infusion for pharmaceutical and biotech clients.
  • Value Communications Provides strategic planning and tactical communications support for HEOR, market access, pricing and reimbursement, and epidemiology programs.
  • iON AI AI-powered intelligence platform built to address the distinct challenges of Medical Affairs. Provides AI-powered capabilities for pharmaceutical and healthcare Medical Affairs teams, supporting scientific and medical information content generation.

Quantifiable outcome

  • Extended services to 24-hour/day coverage through APAC team presence
  • +1 more outcomes

Companies that use Nucleus Global

Customer profile

Named customers4 records

Segments3 records

Ideal customer profiles3 records

Nucleus Global technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature1 record

Nucleus Global partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered core and minor.

  • Inizio MedicalcoreOthersNucleus Global is part of Inizio Medical, a global healthcare consulting and communications group. Inizio Medical provides Nucleus Global with synergies from its global network of offices and access to AI-powered technology platforms like iON AI. The Inizio Medical group includes Ashfield MedComms, ApotheCom, and MEDiSTRAVA.
  • Inizio Medical Network (Ashfield MedComms, ApotheCom, MEDiSTRAVA)coreOthersNucleus Global forms part of Inizio Medical which includes Ashfield MedComms, ApotheCom, and MEDiSTRAVA. This unique position within an international network provides expanded capabilities and resources across medical communications and healthcare consulting.
  • International Society of Medical Publications Professionals (ISMPP)minorStrategic or Co-development PartnerNucleus Global APAC team members are active in ISMPP, driving educational activities, developing region-specific guidance on key medcomms deliverables, and contributing to the advancement of the medcomms profession through publications and professional development.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Nucleus Global competitors and assessment

Company assessment

Direct peers

  • Ashfield MedComms: Sister agency under Inizio Medical offering medical communications, publications, and medical affairs services to pharma and biotech. Direct peer operating in the same category, same parent network, and targeting the same enterprise pharma client base as Nucleus Global.
  • OPEN Health: Global medical communications and HEOR agency offering publications, medical affairs, market access, and patient engagement. Direct peer with overlapping service modules and similar enterprise pharma client base as Nucleus Global.
  • Fishawack Health: Global medical communications and consulting agency serving pharma, biotech, and medtech with publications, medical affairs, and creative services. Direct independent peer with comparable full-service MedComms capabilities and similar top-10 pharma client base.
  • ApotheCom: Sister Inizio Medical agency providing medical communications, publications planning, and scientific content services to biopharma. Direct peer in the same MedComms category, sharing the Inizio Medical network and competing for the same pharma clients as Nucleus Global.
  • MEDiSTRAVA: Sister agency within Inizio Medical focused on medical communications and scientific content for pharma and biotech. Direct peer offering substantially the same service modules (publications, medcomms, digital) as Nucleus Global within the same parent group.

Broad incumbents

  • Real Chemistry: Data-driven healthcare marketing and communications agency offering medcomms, PR, and analytics. Broad incumbent peer competing for pharma communications budgets with proprietary data and AI capabilities Nucleus Global does not own.
  • CMC Connect (IPG Health): Medical communications and scientific engagement agency within IPG Health, serving top-20 pharma with publications and medcomms. Broad incumbent peer with comparable services, overlapping client base, and the backing of a major holding company's healthcare network.
  • McCann Health Medical Communications: Global healthcare communications network within McCann Worldgroup offering medical communications, advertising, and consulting. Broad incumbent competing for the same pharma communications spend as Nucleus Global but at significantly larger scale and creative breadth.
  • Syneos Health Communications: Large CRO and commercialization platform with a medical communications arm serving pharma and biotech. Broad incumbent with deeper clinical development capabilities but overlapping publications and medcomms services versus Nucleus Global.

Others

  • Havas Life: Global healthcare communications network within Havas offering medical communications, advertising, and consulting. Broad incumbent competing for the same pharma communications spend as Nucleus Global at significantly larger scale and creative breadth.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

Nucleus Global social profiles

Digital presence

Nucleus Global financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Nucleus Global leadership team

Management profile

Number of profiles

Profiles6 records

Nucleus Global funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Nucleus Global M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Nucleus Global

What does Nucleus Global do?

Nucleus Global is a global medical communications agency delivering strategic, scientific, and creative communications services to pharmaceutical, biotechnology, and medical device companies. Its core offering spans strategic planning, scientific publications planning and execution, promotional medical communications, medical education, external expert engagement, scientific event management, patient engagement, internal communications and training, creative design, digital solutions, clinical trial support, and value communications (HEOR, market access, pricing and reimbursement). The agency also leverages the parent-group iON AI platform to support Medical Affairs capabilities.

Is Nucleus Global a public or private company?

Nucleus Global is a private company. It is classified as corporate owned and is currently operating.

When was Nucleus Global founded?

Nucleus Global was founded in 1986. It employs 501 to 1,000 people.

Where is Nucleus Global based?

Nucleus Global is headquartered in London, United Kingdom, in the Europe region.

How does Nucleus Global make money?

One revenue line is on record: medical Communications Services.

Who are Nucleus Global's main competitors?

Direct peers on record are Ashfield MedComms, OPEN Health, Fishawack Health, ApotheCom and MEDiSTRAVA. Broad incumbents are Real Chemistry, CMC Connect (IPG Health), McCann Health Medical Communications and Syneos Health Communications. Havas Life is listed as an others.

Does Nucleus Global have an API?

No public API is recorded for Nucleus Global.

What industry is Nucleus Global in?

Nucleus Global's product category is Medical Communications Services. Its primary akta.pro industry code is HLAGAOAG, Medical Affairs, Scientific Communications & HEOR FSP. Its NAICS code is 54169 and its SIC code is 8731.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
openPR.comMedical Writing Market Covering Prime Factors and Competitive Outlook till 2026 || Freyr Solutions, Nucleus Global, Indegene, ICONVerified Market Research published a market analysis report on the global Medical Writing sector, projecting growth driven by increasing clinical trial activity and stricter regulatory documentation requirements. The study identifies key industry players including IQVIA, Parexel, Syneos Health, ICON, Indegene, Freyr Solutions, and Nucleus Global as major contributors to the competitive landscape.InizioInsights from ASCO 2023: #1 – Drug Development and Clinical Trial DesignNucleus Global and Ashfield MedComms published an analysis of ASCO 2023 insights, highlighting advancements in artificial intelligence for drug development, patient-centric clinical trial design using real-world data, and regulatory reforms under FDORA. The report emphasizes the convergence of these technologies and policy changes to improve equitable access to oncology treatments and optimize clinical trial efficiency.PharmaVoiceNucleus Global launches Nucleus X Consulting, specializing in patient engagement and strategic consultancyNucleus Global launched Nucleus X Consulting, a new consultancy specializing in patient engagement and strategic consultancy for rare disease and early-phase medical commercialization. The team aims to partner with clients to drive successful drug commercialization, embedding patient centricity throughout the product lifecycle. The company highlights its focus on rare disease and oncology, working with clients at early stages of commercialization.PR NewswireCD&R baut weltweit führenden medizinischen Kommunikationsdienstleister aufHuntsworth, a portfolio company of private equity firm Clayton, Dubilier & Rice, has completed the previously announced acquisition of Nucleus Global, creating a world-leading medical communications company. The transaction terms were not disclosed. The merger further establishes Huntsworth as a leading pharmaceutical commercialization platform offering services across Medical Affairs, market access, and marketing for large and mid-sized pharma and biotech companies.PR NewswireCD&R crée un leader mondial de la communication médicaleHuntsworth, a Clayton Dubilier & Rice portfolio company, has completed its previously announced acquisition of Nucleus Global, forming a global leader in medical communications. The combined entity becomes a premier pharmaceutical commercialization platform offering medical affairs, market access, and marketing services to large and mid-size pharmaceutical and biotechnology companies. CD&R initially invested in Huntsworth in May 2020, leveraging its experience in healthcare sector investments to support this transaction.PR NewswireCD&R crea un líder mundial en comunicación médicaHuntsworth, a portfolio company of Clayton, Dubilier & Rice (CD&R), has completed the acquisition of Nucleus Global to create a global leader in medical communications. This combination establishes Huntsworth as a leading platform for pharmaceutical marketing, offering medical affairs and market access services to biotech and pharma companies worldwide. The financial terms of the transaction were not disclosed.PR NewswireCD&R Creates Global Medical Communications LeaderHuntsworth, a Clayton, Dubilier & Rice portfolio company, has completed its acquisition of Nucleus Global, creating a global leader in Medical Communications. The combined entity offers medical affairs, market access, and marketing services to pharmaceutical and biotech companies across the drug lifecycle. CD&R made its initial investment in Huntsworth in May 2020, building on the private equity firm's track record of investing in healthcare businesses.HubsHuntsworth expands global health network with Nucleus acquisitionHuntsworth agreed to acquire Nucleus Global, a medical specialist communications network, marking its second acquisition under Clayton, Dubilier & Rice. The deal adds Nucleus's 800+ experts and 14 offices to Huntsworth's healthcare units, expanding services across the drug development lifecycle. Stephen Cameron will join Huntsworth's board and continue leading Nucleus.